Notify me when Nadav Kidron files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Common Stock par value $0.012 per share | 7.6% | $6.86M | 3.12M | Nadav Kidron | Feb 11, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|